Matches in Wikidata for { <http://www.wikidata.org/entity/Q65380371> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q65380371 description "clinical trial" @default.
- Q65380371 description "ensayu clínicu" @default.
- Q65380371 description "klinisch onderzoek" @default.
- Q65380371 description "клінічне випробування" @default.
- Q65380371 name "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 name "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 type Item @default.
- Q65380371 label "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 label "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 prefLabel "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 prefLabel "A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q65380371 P1132 Q65380371-4A61F211-58FD-4BFC-B3C3-B1761BE4225D @default.
- Q65380371 P1476 Q65380371-52E26CB0-CA6F-4295-8A02-0A75ECE54163 @default.
- Q65380371 P17 Q65380371-03AB6F27-9F63-4C7B-8552-028091918DFF @default.
- Q65380371 P17 Q65380371-12FEE70B-13DA-4F30-B4A4-C30558583083 @default.
- Q65380371 P17 Q65380371-13C41543-AB54-497E-9B70-2F7F8A9E9FDB @default.
- Q65380371 P17 Q65380371-1B815BD5-7C10-4E2E-AA97-60847B78174A @default.
- Q65380371 P17 Q65380371-1E6C6111-0D75-453F-A16D-3EE7DEF987E9 @default.
- Q65380371 P17 Q65380371-22FC37CD-F207-4A3E-9BBF-FB25998E3535 @default.
- Q65380371 P17 Q65380371-2F7A034A-A8BC-4D5C-B6AC-F09C82314F63 @default.
- Q65380371 P17 Q65380371-4C1C7A21-A623-48B6-BA2C-CCECD60BF421 @default.
- Q65380371 P17 Q65380371-4D013C43-6D9A-4F34-9DDD-37E6CCA90662 @default.
- Q65380371 P17 Q65380371-590FC06D-E8DB-4104-BD8A-159CE4E57275 @default.
- Q65380371 P17 Q65380371-6352D9B7-2EA6-4195-88D2-557A01DF5C55 @default.
- Q65380371 P17 Q65380371-6541518B-77F8-40F7-9F99-CFA729FE289E @default.
- Q65380371 P17 Q65380371-680F1D17-1244-4BFE-8F04-64B303470EA5 @default.
- Q65380371 P17 Q65380371-8A594113-AF66-498D-BC57-C651E5AF9047 @default.
- Q65380371 P17 Q65380371-94009B26-4E89-4A87-AEAC-380C6F376B78 @default.
- Q65380371 P17 Q65380371-A2072E29-73FE-4321-9C99-4B7729DD0BC7 @default.
- Q65380371 P17 Q65380371-A6D42157-830A-4870-AB6F-F42283A574C5 @default.
- Q65380371 P17 Q65380371-BFBC382B-319C-4872-ADDF-0FD0A6C10E62 @default.
- Q65380371 P17 Q65380371-D5882C22-A6A8-44CF-925F-FA29622082A3 @default.
- Q65380371 P17 Q65380371-DC92A594-7390-49B8-83BE-D523F9476D8C @default.
- Q65380371 P17 Q65380371-DDE5618A-7C7E-49CD-8DA3-D44CF632FE96 @default.
- Q65380371 P17 Q65380371-E6B1AC90-D040-4106-A766-C97186DBA921 @default.
- Q65380371 P17 Q65380371-EB757C1B-D5D3-4DF3-89D1-8E90732E8503 @default.
- Q65380371 P17 Q65380371-F4C49D96-D494-44D0-AE89-32A667466438 @default.
- Q65380371 P17 Q65380371-FEF44273-0C63-4217-90DD-E71A7F1A8982 @default.
- Q65380371 P2899 Q65380371-6537E0A6-E882-45AA-91BE-538AA3537ED1 @default.
- Q65380371 P3098 Q65380371-FFC956BF-B9E1-4CEA-9F0F-1BBF53E27624 @default.
- Q65380371 P31 Q65380371-51C09394-4D7B-413C-B73F-CC32A1F26015 @default.
- Q65380371 P580 Q65380371-1D414A13-DEE4-4196-91CF-554981D22293 @default.
- Q65380371 P582 Q65380371-C0D13E94-2316-48B9-97C5-EC2A538D79C8 @default.
- Q65380371 P6099 Q65380371-0D0EFF8F-1181-4345-844E-0BC0369723E4 @default.
- Q65380371 P8363 Q65380371-D243230F-0196-4CC9-A34A-01C8116699F8 @default.
- Q65380371 P859 Q65380371-BBBB8C67-59E0-4586-818F-88E9CF579A51 @default.
- Q65380371 P1132 "+889" @default.
- Q65380371 P1476 "A Randomized, Double-blind Study to Evaluate the Effect of Tarceva or Placebo Following Platinum-based CT on Overall Survival and Disease Progression in Patients With Advanced, Recurrent or Metastatic NSCLS Who Have Not Experienced Disease Progression or Unacceptable Toxicity During Chemotherapy" @default.
- Q65380371 P17 Q142 @default.
- Q65380371 P17 Q145 @default.
- Q65380371 P17 Q16 @default.
- Q65380371 P17 Q183 @default.
- Q65380371 P17 Q212 @default.
- Q65380371 P17 Q213 @default.
- Q65380371 P17 Q214 @default.
- Q65380371 P17 Q215 @default.
- Q65380371 P17 Q218 @default.
- Q65380371 P17 Q258 @default.
- Q65380371 P17 Q28 @default.
- Q65380371 P17 Q29 @default.
- Q65380371 P17 Q298 @default.
- Q65380371 P17 Q31 @default.
- Q65380371 P17 Q35 @default.
- Q65380371 P17 Q36 @default.
- Q65380371 P17 Q37 @default.
- Q65380371 P17 Q38 @default.
- Q65380371 P17 Q40 @default.
- Q65380371 P17 Q408 @default.
- Q65380371 P17 Q41 @default.
- Q65380371 P17 Q55 @default.
- Q65380371 P17 Q664 @default.
- Q65380371 P17 Q717 @default.
- Q65380371 P17 Q833 @default.
- Q65380371 P2899 "+18" @default.
- Q65380371 P3098 "NCT00556712" @default.
- Q65380371 P31 Q30612 @default.
- Q65380371 P580 "2006-01-01T00:00:00Z" @default.
- Q65380371 P582 "2010-11-01T00:00:00Z" @default.
- Q65380371 P6099 Q42824827 @default.
- Q65380371 P8363 Q78089383 @default.
- Q65380371 P859 Q212646 @default.